CANF

Can-Fite BioPharma
CANF

Overview Fund Trends Analyst Outlook Journalist POV

12 hedge funds and large institutions have $465K invested in Can-Fite BioPharma in 2022 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

less capital invested

Capital invested by funds: $ → $

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

Holders
12
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$52K
2
+$43K
3
+$31.4K
4
UBS Group
UBS Group
Switzerland
+$316

Top Sellers

1
-$14K
2
-$2K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$311K
2
$52K
3
$43K
4
$28K
5
$11K
6
$7K
7
$5K
8
$5K
9
$1.01K
10
$1K
11
$490
12
$233
13
–
14
–